SOD2 and stage 5 chronic kidney disease: It is important to note that polymorphic expression of either SOD2 and/or GPX1 influences susceptibility to end-stage renal disease (ESRD) and transitional cell carcinoma (TCC), both associated with BEN progression and complications [29,30,31].